OpenMedicare
Start Here
Explore
Fraud
Investigations
Data
Tools
About

Footer

OpenMedicare

Independent Medicare data journalism

Sister Sites

  • OpenMedicaid
  • OpenFeds
  • OpenSpending

Explore

  • Providers
  • Procedures
  • States
  • Specialties
  • Search

Fraud Analysis

  • Still Out There (AI)
  • Fraud Overview
  • Fraud Watchlist
  • Deep Dive Profiles
  • Impossible Numbers
  • Report Fraud

Investigations

  • The Algorithm Knows
  • How We Built the Model
  • Internal Medicine Crisis
  • Florida & California Fraud
  • Million Dollar Flagged
  • All Investigations

Tools

  • Provider Lookup
  • Compare
  • Cost Calculator
  • Your Medicare Dollar
  • Downloads

About

  • About OpenMedicare
  • Methodology
  • Glossary
  • Data Sources
  • API Docs
  • Updates
Data Sources: Centers for Medicare & Medicaid Services (CMS), Medicare Provider Utilization and Payment Data
Disclaimer: This site is an independent journalism project. Data analysis and editorial content are not affiliated with or endorsed by CMS or any government agency. All spending figures are based on publicly available Medicare payment records.
Sister Sites: OpenMedicaid · OpenFeds · OpenSpending

© 2026 OpenMedicare. Independent data journalism. Built by TheDataProject.ai

Methodology•Download Data
  1. Home
  2. Procedures
  3. J1437
  4. Cost Analysis

How Much Does Injection, ferric derisomaltose, 10 mg Cost on Medicare?

Cost analysis for CPT J1437 — Injection, ferric derisomaltose, 10 mg

Share:

Average Medicare Payment

$16.44

2023 data

Total Payments (2023)

$35.3M

Services (2023)

2.1M

Price Change (2020–2023)

-21.3%

📈 Year-over-Year Cost Trend

YearAvg PaymentTotal PaymentsServicesYoY Change
2020$20.90$35.5K1.7K—
2021$20.77$4.4M213.1K-0.6%
2022$18.43$13.1M710.7K-11.3%
2023$16.44$35.3M2.1M-10.8%

🗺️ State-by-State Cost Variation

The most expensive state pays 1.1x more than the cheapest for this procedure. NH averages $17.14 vs KY at $15.87.

StateAvg PaymentTotal PaymentsServicesProviders
NH$17.14$24.5K1.4K1
NY$17.09$114.5K6.7K4
MA$16.91$64.2K3.8K2
WI$16.78$31.9K1.9K1
CT$16.66$90.0K5.4K3
NJ$16.62$2.3M137.2K29
AR$16.62$2.6M155.8K24
AL$16.61$2.5M149.4K42
IL$16.56$462.0K27.9K12
TX$16.56$312.9K18.9K4
UT$16.55$140.7K8.5K4
FL$16.55$6.5M394.7K109
SC$16.55$1.5M91.1K14
NC$16.53$2.1M125.6K29
OH$16.51$592.9K35.9K17
KS$16.51$289.0K17.5K6
IN$16.50$1.1M65.8K18
OK$16.50$481.9K29.2K3
WA$16.49$52.8K3.2K2
TN$16.45$1.8M110.2K21
PA$16.44$3.1M190.9K60
MD$16.44$3.6M219.4K48
AZ$16.44$397.3K24.2K15
VA$16.43$563.4K34.3K17
AK$16.42$34.5K2.1K1
ND$16.42$75.5K4.6K1
DE$16.39$329.5K20.1K7
MO$16.38$391.5K23.9K9
CA$16.32$1.0M62.0K21
VT$16.29$118.9K7.3K1
SD$16.23$43.8K2.7K1
CO$16.19$113.4K7.0K5
MI$16.11$198.1K12.3K5
LA$16.10$334.9K20.8K8
MS$15.98$92.7K5.8K4
GA$15.90$1.8M113.4K32
KY$15.87$42.9K2.7K1

💰 Who Bills the Most for This Procedure?

ProviderSpecialtyStatePaymentsServicesAvg/Service
Michael AuerbachHematology-OncologyMD$431.3K25.9K$16.65
Andrew WeberHematology-OncologyFL$286.9K17.2K$16.68
Pablo ReyesHematology-OncologyFL$283.7K17.1K$16.59
Mitchell MartinMedical OncologyTN$281.4K16.9K$16.65
Huzefa BahrainMedical OncologyMD$273.8K16.6K$16.49
Balagopalan NairHematology-OncologyAR$265.1K15.9K$16.67
Sanjaykumar HapaniMedical OncologyOK$264.7K16.0K$16.54
John WaplesHematology-OncologyAL$249.3K15.0K$16.62
Daniel IbachHematology-OncologyTN$244.9K14.8K$16.55
Bhavesh BalarHematology-OncologyNJ$229.9K13.8K$16.66
Vijay PaudelHematology-OncologySC$220.6K13.3K$16.59
Navneet MittalHematology-OncologyTX$215.6K13.0K$16.58
Ross KernsHematology-OncologyTN$214.2K12.8K$16.74
Dejuania Brown-RawlsHematology-OncologySC$204.4K12.5K$16.35
Nagesh JayaramHematology-OncologyNC$199.0K12.0K$16.58
Keith LerroHematology-OncologyNC$198.2K11.9K$16.65
Anju VasudevanHematology-OncologyFL$195.9K11.8K$16.60
Omer KhalilHematology-OncologyAR$195.3K11.7K$16.69
Jay NayakHematology-OncologySC$188.1K11.3K$16.65
Mohit NarangHematology-OncologyMD$187.8K11.2K$16.77

🤔 Is Injection, ferric derisomaltose, 10 mg Overpriced?

Based on the data, CPT J1437 shows a 1.1x variation in pricing across states — relatively consistent by Medicare standards.

Costs have decreased 21.3% since 2020. Medicare's fee schedule attempts to standardize pricing, though some variation is expected due to geographic cost-of-living adjustments and practice expense differences.

This analysis is based on publicly available CMS data and does not account for patient complexity, comorbidities, or facility-specific factors that may justify pricing differences.

Data Sources

  • • Centers for Medicare & Medicaid Services (CMS)
  • • Medicare Provider Utilization and Payment Data (2014-2023)
  • • Medicare Physician Fee Schedule

Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.